Goldman Sachs analyst removed downgraded HCA Healthcare from the firm’s Conviction List as part of its monthly update but keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare price target lowered to $280 from $310 at Deutsche Bank
- HCA Healthcare price target lowered to $254 from $267 at Wells Fargo
- HCA Healthcare price target lowered to $276 from $298 at Leerink
- HCA Healthcare price target lowered to $300 from $340 at Truist
- HCA Healthcare price target lowered to $280 from $300 at Stephens
